Form D · Other Health Care
Panacea BioMatx, Inc.
Research Triangle Park, NC · CIK 0001605753
Offering snapshot reported Apr 16, 2014 · SEC filing
- Reported sold
- $267K Offering amount: $500K
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $2K Reported outside-investor minimum
- First sale
- Apr 1, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 16, 2014 | Initial | $267,318 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-215722
The Company has reserved the right to increase the offering to $1,000,000.
No sales commissions or finders fees have been paid or will be paid with respect to this offering.
Source: Form D, filed Apr 16, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Joseph Eshelman Bourn | Executive |
| Edison Thurman Hudson | Director, Executive |
| Lloyd Staton Noel | Director, Executive |
| Thomas H. Roberg | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2 Davis Drive
Research Triangle Park, NC, 27709
Research Triangle Park, NC, 27709